Catalyst Wire Dossier Catalyst Wire Dossier

Panhematin

heme arginate (hemin)
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Panhematin, covering 2014-10-24 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Panhematin for Prevention of Acute Attacks of Porphyria [Phase 2]

See pricing